Bacterial meningitis

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão das evidências: 17 Aug 2026
Última atualização do tópico: 14 Aug 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • headache
  • neck stiffness
  • fever
  • altered mental status
  • confusion
  • photophobia
  • vomiting
  • seizures
  • hypothermia (infants)
  • irritability (infants)
  • lethargy (infants)
  • poor feeding (infants)
  • apnea (infants)
  • focal neurologic deficit
  • abnormal eye movement
  • facial palsy
  • balance problems/hearing impairment
  • bulging fontanel in infants
Detalhes completos

Outros fatores diagnósticos

  • high-pitched cry (infants)
  • rash
  • papilledema
  • Kernig sign
  • Brudzinski sign
Detalhes completos

Fatores de risco

  • age ≤5 or ≥65 years
  • crowding
  • exposure to pathogens
  • nonimmunized infants
  • immunodeficiency
  • cancer
  • asplenia/hyposplenic state
  • cranial anatomic defects
  • cochlear implants
  • contiguous infection
  • smoking
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • cerebrospinal fluid (CSF) cell count and differential
  • cerebrospinal fluid (CSF) protein
  • cerebrospinal fluid (CSF) glucose
  • cerebrospinal fluid (CSF) Gram stain
  • cerebrospinal fluid (CSF) culture
  • antigen detection in cerebrospinal fluid (CSF)
  • blood culture
  • CBC and differential
  • CRP
  • electrolytes, calcium (Ca), magnesium (Mg), glucose
  • coagulation profile (prothrombin time, INR, activated PTT, fibrinogen, fibrin degradation products)
  • CT head
  • polymerase chain reaction (PCR)
Detalhes completos

Investigações a serem consideradas

  • MRI head
  • transcranial Doppler
  • serum procalcitonin
Detalhes completos

Novos exames

  • heparin-binding protein (HBP)
  • rapid antigen cerebrospinal fluid (CSF) tests
  • metagenomic next-generation sequencing (mNGS)
Detalhes completos

Algoritmo de tratamento

Inicial

≤1 month of age and immunocompetent

>1 month and <50 years of age and immunocompetent

≥50 years of age or immunocompromised

AGUDA

confirmed infection: Streptococcus pneumoniae

confirmed infection: Haemophilus influenzae

confirmed infection: Streptococcus agalactiae (group B streptococci)

confirmed infection: Escherichia coli and other gram-negative Enterobacteriaceae

confirmed infection: Listeria monocytogenes

confirmed infection: Staphylococcus aureus

confirmed infection: Staphylococcus epidermidis

confirmed infection: Pseudomonas aeruginosa

confirmed infection: Enterococcus species

confirmed infection: Acinetobacter species

confirmed infection: Neisseria meningitidis

Colaboradores

Consultores especialistas

Rodrigo Hasbun, MD, MPH

Professor of Medicine

UT Health Mc Govern Medical School

Houston, TX

Declarações

RH has received research support and personal fees from Biomeriaux. RH is an author of references cited in this topic.

Omaima El Tahir, MD

PhD Candidate

Department of Pediatric infectious Diseases and Immunology, AI&II

Amsterdam UMC, Vrije Universiteit Amsterdam

Amsterdam

The Netherlands

Declarações

OET declares that she has no competing interests.

Agradecimentos

Dr Rodrigo Hasbun and Omaima El Tahir would like to gratefully acknowledge Dr Marceline Tutu van Furth, previous contributor to this topic.

Declarações

AMTvF declares that she has no competing interests.

Revisores

Catherine Derber, MD

Professor

Department of Medicine

Eastern Virginia Medical School

Norfolk, VA

Declarações

CD declares that she has no competing interests.

Guy Thwaites, MA, MBBS, PhD, MRCP, FRCPath

Wellcome Trust Clinical Research Fellow

Centre for Molecular Microbiology and Infection

Imperial College London

London

UK

Declarações

GT declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Hasbun R. Progress and challenges in bacterial meningitis: a review. JAMA. 2022 Dec 6;328(21):2147-54. Resumo

van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22(suppl 3):S37-62.Texto completo  Resumo

Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Bacterial meningitis images
  • Diagnósticos diferenciais

    • Encephalitis
    • Viral meningitis
    • Drug-induced meningitis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis
    • ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
    Mais Diretrizes
  • Videos

    Diagnostic lumbar puncture in adults: animated demonstration

    Venepuncture and phlebotomy: animated demonstration

    Mais vídeos
  • Folhetos informativos para os pacientes

    Meningitis and septicemia

    Pneumococcal vaccine in babies and children

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal